Peter W. Albers

Peter W. Albers

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 334 publications

From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?

From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?

Journal: European urology

Published: April 29, 2026

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

Journal: European urology

Published: April 15, 2026

The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and Risks.

The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and Risks.

Journal: Deutsches Arzteblatt international

Published: April 09, 2026

Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?

Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?

Journal: Urologie (Heidelberg, Germany)

Published: April 01, 2026

MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.

MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.

Journal: European urology oncology

Published: March 08, 2026

Smart Screening in Prostate Cancer: What We Have Learned So Far from PROBASE.

Smart Screening in Prostate Cancer: What We Have Learned So Far from PROBASE.

Journal: European urology focus

Published: March 02, 2026

Title Not Found

Title Not Found

Journal: Aktuelle Urologie

Published: February 16, 2026

Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.

Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.

Journal: European urology open science

Published: December 23, 2025

Early detection of prostate cancer-recommendations of the updated S3 guideline 2025

Early detection of prostate cancer-recommendations of the updated S3 guideline 2025

Journal: Urologie (Heidelberg, Germany)

Published: December 07, 2025

Motivations and experiences of high-risk men in risk-adapted prostate cancer early detection: A qualitative study.

Motivations and experiences of high-risk men in risk-adapted prostate cancer early detection: A qualitative study.

Journal: Patient education and counseling

Published: November 25, 2025

Expanding Risk-adapted Early Detection of Prostate Cancer: A Call to Action for Men at High Risk.

Expanding Risk-adapted Early Detection of Prostate Cancer: A Call to Action for Men at High Risk.

Journal: European urology oncology

Published: November 24, 2025

Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review.

Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: November 13, 2025

Showing 1-12 of 334

Last Updated: 09/26/2026